Imgatuzumab (Anti-ERBB1 / EGFR / HER1)

Imgatuzumab (Anti-ERBB1 / EGFR / HER1) is a glycoengineered monoclonal antibody directed against the epidermal growth factor receptor (EGFR) with potential antineoplastic activity. MW: 145.28 KD.

• Supplier: Selleck Chemicals
• Product #: A2889
• Sku #: A2889-1mg*25